These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 25461771)

  • 1. PTEN hamartoma tumor syndrome: clinical risk assessment and management protocol.
    Ngeow J; Eng C
    Methods; 2015 May; 77-78():11-9. PubMed ID: 25461771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTEN in Hereditary and Sporadic Cancer.
    Ngeow J; Eng C
    Cold Spring Harb Perspect Med; 2020 Apr; 10(4):. PubMed ID: 31570378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline PTEN Mutation Analysis for PTEN Hamartoma Tumor Syndrome.
    Ngeow J; Eng C
    Methods Mol Biol; 2016; 1388():63-73. PubMed ID: 27033071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer risk and clinical implications for germline PTEN mutation carriers.
    Ngeow J; Sesock K; Eng C
    Breast Cancer Res Treat; 2017 Aug; 165(1):1-8. PubMed ID: 26700035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline epigenetic regulation of KILLIN in Cowden and Cowden-like syndrome.
    Bennett KL; Mester J; Eng C
    JAMA; 2010 Dec; 304(24):2724-31. PubMed ID: 21177507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cowden syndrome.
    Gustafson S; Zbuk KM; Scacheri C; Eng C
    Semin Oncol; 2007 Oct; 34(5):428-34. PubMed ID: 17920899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cowden syndrome: report of two cases with immunohistochemical analysis for PTEN expression.
    Zabetian S; Mehregan D
    Am J Dermatopathol; 2012 Aug; 34(6):632-4. PubMed ID: 22481496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cowden disease and the PTEN gene: a successfully clinical and biological combined approach].
    Longy M
    Bull Cancer; 2001 Dec; 88(12):1153-8. PubMed ID: 11792608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting Germline PTEN Mutations Among At-Risk Patients With Cancer: An Age- and Sex-Specific Cost-Effectiveness Analysis.
    Ngeow J; Liu C; Zhou K; Frick KD; Matchar DB; Eng C
    J Clin Oncol; 2015 Aug; 33(23):2537-44. PubMed ID: 26169622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN hamartoma tumor syndrome.
    Mester J; Charis E
    Handb Clin Neurol; 2015; 132():129-37. PubMed ID: 26564076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTEN Mutation Identified in Patient Diagnosed with Simultaneous Multiple Cancers.
    Won HS; Chang ED; Na SJ; Whang IY; Lee DS; You SH; Kim YS; Kim JS
    Cancer Res Treat; 2019 Jan; 51(1):402-407. PubMed ID: 29510612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a Cowden syndrome patient with a novel PTEN mutation and establishment of patient-derived induced pluripotent stem cells.
    Obayashi F; Hamada A; Yamasaki S; Kanda T; Toratani S; Okamoto T
    In Vitro Cell Dev Biol Anim; 2022 Jan; 58(1):69-78. PubMed ID: 34984555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unexpected cancer-predisposition gene variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome patients without underlying germline PTEN mutations.
    Yehia L; Ni Y; Sesock K; Niazi F; Fletcher B; Chen HJL; LaFramboise T; Eng C
    PLoS Genet; 2018 Apr; 14(4):e1007352. PubMed ID: 29684080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria.
    Pilarski R; Burt R; Kohlman W; Pho L; Shannon KM; Swisher E
    J Natl Cancer Inst; 2013 Nov; 105(21):1607-16. PubMed ID: 24136893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome.
    Marsh DJ; Kum JB; Lunetta KL; Bennett MJ; Gorlin RJ; Ahmed SF; Bodurtha J; Crowe C; Curtis MA; Dasouki M; Dunn T; Feit H; Geraghty MT; Graham JM; Hodgson SV; Hunter A; Korf BR; Manchester D; Miesfeldt S; Murday VA; Nathanson KL; Parisi M; Pober B; Romano C; Eng C
    Hum Mol Genet; 1999 Aug; 8(8):1461-72. PubMed ID: 10400993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Implications for Germline PTEN Spectrum Disorders.
    Ngeow J; Sesock K; Eng C
    Endocrinol Metab Clin North Am; 2017 Jun; 46(2):503-517. PubMed ID: 28476234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTEN: one gene, many syndromes.
    Eng C
    Hum Mutat; 2003 Sep; 22(3):183-98. PubMed ID: 12938083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WWP1 Gain-of-Function Inactivation of PTEN in Cancer Predisposition.
    Lee YR; Yehia L; Kishikawa T; Ni Y; Leach B; Zhang J; Panch N; Liu J; Wei W; Eng C; Pandolfi PP
    N Engl J Med; 2020 May; 382(22):2103-2116. PubMed ID: 32459922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome.
    Orloff MS; Eng C
    Oncogene; 2008 Sep; 27(41):5387-97. PubMed ID: 18794875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTEN lipid phosphatase activity and proper subcellular localization are necessary and sufficient for down-regulating AKT phosphorylation in the nucleus in Cowden syndrome.
    He X; Saji M; Radhakrishnan D; Romigh T; Ngeow J; Yu Q; Wang Y; Ringel MD; Eng C
    J Clin Endocrinol Metab; 2012 Nov; 97(11):E2179-87. PubMed ID: 22962422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.